INVO Fertility Files 2025 10-K, Plans Q1 10-Q After $7.5M Financing and Clinic Acquisition
IVF•INVO Fertility filed its delayed 2025 10-K on June 2, 2026, after receiving a Nasdaq notice for late 10-K and Q1 2026 10-Q filings. The company plans to finalize its 10-Q while building on a $7.5 million January financing and the Family Beginnings clinic acquisition.
1. Nasdaq Notification for Late Filings
On May 27, 2026, INVO Fertility received a delinquency notice from Nasdaq’s Listing Qualifications Staff for failing to timely file its annual Form 10-K and first quarter Form 10-Q as required by Listing Rule 5250(c)(1).
2. 10-K Filed; Q1 10-Q Pending
The company filed its 2025 10-K with the SEC on June 2, 2026 and is working to complete its March 31, 2026 10-Q, citing additional reviews of its tax provision, variable interest entities and derivative accounting as the cause of delays.
3. $7.5M Financing and Clinic Acquisition
INVO Fertility closed a $7.5 million financing in January 2026 and acquired Family Beginnings, an Indiana-based fertility clinic, steps which management says strengthen its operations, balance sheet and growth strategy.
4. Compliance Plan Deadline and Extensions
Pursuant to Nasdaq rules, the company must submit a compliance plan by June 22, 2026, with the potential to regain compliance by October 13, 2026 if the plan is accepted or to appeal to a hearings panel if not.
